Fetal-cell microchimerism, lymphopoiesis, and autoimmunity

Area of Science:

• Immunology
• Reproductive Biology
• Genetics

Background:

• Fetal cells and microchimerism are found in mothers long after pregnancy.
• Fetal microchimerism (FMc) has been linked to autoimmunity, particularly systemic sclerosis.
• Previous hypotheses focused on fetal T cells causing graft-versus-host disease.

Purpose of the Study:

• To review the immune consequences of fetal cell persistence in maternal tissues.
• To re-evaluate the role of fetal microchimerism in autoimmune disorders.
• To explore alternative explanations for the association between FMc and autoimmunity.

Main Methods:

• Review of existing literature on fetal microchimerism and maternal immune responses.
• Analysis of studies investigating fetal progenitor cell transfer and function.
• Discussion of immunological tolerance mechanisms.

Main Results:

• Fetal cells, including progenitor cells, transfer to mothers and can persist.
• Fetal hematopoietic progenitor cells can develop into T and B cells within maternal tissues.
• This development involves an educational process potentially leading to maternal antigen tolerance.

Conclusions:

• The presence of fetal T cells alone may not directly cause autoimmunity.
• Fetal progenitor cells maturing in maternal tissues might induce tolerance rather than disease.
• Alternative hypotheses beyond direct fetal cell transfer are needed to explain FMc's association with autoimmune disorders.